Control (placebo)
Sponsors
Hartford Hospital, Karolinska Institutet, Hurd,Yasmin, Ph.D., University of Reading, University of Seoul
Conditions
Attentional ImpairmentBioequivalenceCardiometabolic Risk MarkersCardiovascular RiskColorectal AdenomaDefecation FrequencyExerciseHealth Adult Subjects
Early Phase 1
Cognitive Remediation for Neuropsychological Impairment in Compulsive Hoarding
CompletedNCT01451697
Start: 2011-07-31End: 2012-10-31Target: 20Updated: 2019-05-20
Renewal-NAD+: A Study of Oral NAD+ and Its Multi-omic Impact in a Healthy Cohort
CompletedNCT07336836
Start: 2022-02-23End: 2022-06-04Updated: 2026-01-13
Phase 2
Phase 4
Study on the Effect of Granisetron on Myofascial Pain in the Orofacial Muscles
CompletedNCT02230371
Start: 2007-03-31End: 2014-12-31Updated: 2021-03-24
This Randomized Trial Aims to Investigate the Efficacy of Balanced Nutritional Tablets-Comprehensive Multivitamin and Mineral Supplements- in Preventing Micronutrient Deficiencies Among Patients Utilizing GLP-1 RAs for Weight Loss in Comparison to a Placebo Control
RecruitingNCT06981936
Start: 2025-05-15End: 2026-05-31Target: 150Updated: 2025-09-16
The Effect of Oral Clostridium Butyricum on the Recurrence After Colonoscopic Resection of Colorectal Adenoma
RecruitingNCT07167342
Start: 2026-05-22End: 2030-04-30Target: 294Updated: 2026-05-26
Unknown Phase
Coffee Bioequivalence Trial
Not yet recruitingNCT06758531
Start: 2025-01-31End: 2025-12-30Target: 16Updated: 2025-01-03
The Effects of 8-week Resistance and Aerobic Exercise on Anxiety, Depression, Sleep, Inhibitory Control in Young Adults With Smartphone Overdependence
CompletedNCT06848322
Start: 2025-01-06End: 2025-02-05Updated: 2025-02-27
Yeast Mannans and Stool Frequency
Active, not recruitingNCT06911177
Start: 2025-07-17End: 2026-12-31Target: 70Updated: 2026-04-15
Daily Amino Acid Supplementation for People With Parkinson's Disease
RecruitingNCT07115563
Start: 2025-10-31End: 2027-11-01Target: 30Updated: 2026-07-02
Effect of CPP-ACP Associated With NaF or SnF₂ on Post-Bleaching Tooth Sensitivity
CompletedNCT07506850
Start: 2025-02-05End: 2026-01-29Updated: 2026-04-02